Company profile: Rejuvenate Biomed
1.1 - Company Overview
Company description
- Provider of science-based healthy aging drug development and discovery platforms by repositioning approved drugs. Offers RJx-01, a proprietary oral combination of metformin and galantamine for sarcopenia; CombinAge, an AI-enabled in silico platform to discover drug combinations for age-related diseases; and CelegAge, a C. elegans in vivo platform evaluating the impact of synergistic drug combinations on healthspan markers.
Products and services
- CelegAgeTM: Medium-throughput platform using C. elegans that evaluates the impact of synergistic drug combinations on healthspan markers
- CombinAgeTM: AI-enabled platform that discovers drug combinations with potential to treat age-related diseases using computational modeling to identify promising multi-drug regimens
- RJx-01: Oral combination drug composed of metformin and galantamine engineered to treat sarcopenia by improving muscle mass, strength, and physical performance in aging individuals
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Rejuvenate Biomed
Precision Spine
HQ: United States
Website
- Description: Provider of spinal pathology solutions and a Made in the USA manufacturer and global distributor of spinal products for hospitals, orthopedic surgeons, neurosurgeons and insurance companies. Comprehensive portfolio includes ACDF standalone systems; modular, titanium and HA-coated pedicle screw systems; anterior cervical plating systems; and interbody systems with titanium plasma spray and HA coating.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Precision Spine company profile →
Miach Orthopaedics
HQ: United States
Website
- Description: Provider of medical devices that facilitate new tissue growth, including the BEAR Implant, a bovine extracellular matrix collagen-based implant designed to treat anterior cruciate ligament (ACL) injuries by facilitating the body's own healing process.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Miach Orthopaedics company profile →
LDR
HQ: United States
Website
- Description: Provider of implantable spine systems and instrumentation for spine treatments and surgeries, offering cervical and lumbar artificial disc systems, pedicle screw systems, implant systems, cervical cages, and synthetic bone substitutes; serving patients and the surgeon community in the United States and internationally.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LDR company profile →
Össur
HQ: Iceland
Website
- Description: Provider of high-technology orthotic and prosthetic devices and non-invasive mobility solutions. Develops, manufactures, distributes, sells and markets products including the Proprio Foot microprocessor-controlled ankle, i-Digits Quantum myoelectric partial-hand prosthesis, Direct Socket TF transfemoral socket system, and Unloader One knee osteoarthritis brace.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Össur company profile →
Non-Invasive Monitoring Systems
HQ: United States
Website
- Description: Provider of health care products manufacturing and research in human muscle relaxation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Non-Invasive Monitoring Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Rejuvenate Biomed
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Rejuvenate Biomed
2.2 - Growth funds investing in similar companies to Rejuvenate Biomed
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Rejuvenate Biomed
4.2 - Public trading comparable groups for Rejuvenate Biomed
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →